Scientists have welcomed positive data on potential treatments and progress on testing. But warn that vaccine timelines look ambitious and argue more thought is needed on manufacturing. Remdesivir was granted emergency use authorization by the u.s. food and drug administration for covid-19 on friday. The european medicines agency announced a rolling- review of remdesivir, which enables the agency to assess data on the drug as it becomes available.

Get our Emerging Markets updates for free every morning!

Leave a Reply

Your email address will not be published.